A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis.
TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS